Keywords: rosetta, genomics, transfers, project, isis, regulus, firm

Rosetta Genomics transfers project with Isis to Regulus

Article | 29 September 2008

Rosetta Genomics, a US firm specializing on the development of microRNA-based diagnostics and therapeutics, has transferred its microRNA-based liver cancer ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Regulus Therapeutics

Go to company listing